Literature DB >> 21859376

Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.

Xiaodong Ye1, Diane Fels, Artak Tovmasyan, Katherine M Aird, Casey Dedeugd, Jennifer L Allensworth, Ivan Kos, Won Park, Ivan Spasojevic, Gayathri R Devi, Mark W Dewhirst, Kam W Leong, Ines Batinic-Haberle.   

Abstract

Due to the ability to easily accept and donate electrons Mn(III)N-alkylpyridylporphyrins (MnPs) can dismute O(2)(·-), reduce peroxynitrite, but also generate reactive species and behave as pro-oxidants if conditions favour such action. Herein two ortho isomers, MnTE-2-PyP(5+), MnTnHex-2-PyP(5+), and a meta isomer MnTnHex-3-PyP(5+), which differ greatly with regard to their metal-centered reduction potential, E(1/2) (Mn(III)P/Mn(II)P) and lipophilicity, were explored. Employing Mn(III)P/Mn(II)P redox system for coupling with ascorbate, these MnPs catalyze ascorbate oxidation and thus peroxide production. Consequently, cancer oxidative burden may be enhanced, which in turn would suppress its growth. Cytotoxic effects on Caco-2, Hela, 4T1, HCT116 and SUM149 were studied. When combined with ascorbate, MnPs killed cancer cells via peroxide produced outside of the cell. MnTE-2-PyP(5+) was the most efficacious catalyst for peroxide production, while MnTnHex-3-PyP(5+) is most prone to oxidative degradation with H(2) , and thus the least efficacious. A 4T1 breast cancer mouse study of limited scope and success was conducted. The tumour oxidative stress was enhanced and its microvessel density reduced when mice were treated either with ascorbate or MnP/ascorbate; the trend towards tumour growth suppression was detected.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21859376      PMCID: PMC3500602          DOI: 10.3109/10715762.2011.616199

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  79 in total

1.  Reactions of manganese porphyrins and manganese-superoxide dismutase with peroxynitrite.

Authors:  Gerardo Ferrer-Sueta; Celia Quijano; Beatriz Alvarez; Rafael Radi
Journal:  Methods Enzymol       Date:  2002       Impact factor: 1.600

2.  Determination of n-octanol/water partition and membrane binding of cationic porphyrins.

Authors:  Fábio M Engelmann; Silvia V O Rocha; Henrique E Toma; Koiti Araki; Maurício S Baptista
Journal:  Int J Pharm       Date:  2006-08-17       Impact factor: 5.875

3.  Long-term neuroprotection from a potent redox-modulating metalloporphyrin in the rat.

Authors:  Huaxin Sheng; Wei Yang; Shiro Fukuda; Hubert M Tse; Wulf Paschen; Kwame Johnson; Ines Batinic-Haberle; James D Crapo; Robert D Pearlstein; Jon Piganelli; David S Warner
Journal:  Free Radic Biol Med       Date:  2009-07-22       Impact factor: 7.376

Review 4.  Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide.

Authors:  Garry R Buettner
Journal:  Anticancer Agents Med Chem       Date:  2011-05-01       Impact factor: 2.505

5.  Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants.

Authors:  G Ferrer-Sueta; I Batinić-Haberle; I Spasojević; I Fridovich; R Radi
Journal:  Chem Res Toxicol       Date:  1999-05       Impact factor: 3.739

6.  Expression of CD38 increases intracellular calcium concentration and reduces doubling time in HeLa and 3T3 cells.

Authors:  E Zocchi; A Daga; C Usai; L Franco; L Guida; S Bruzzone; A Costa; C Marchetti; A De Flora
Journal:  J Biol Chem       Date:  1998-04-03       Impact factor: 5.157

7.  Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death.

Authors:  Raphael Beck; Julien Verrax; Thomas Gonze; Marianne Zappone; Rozangela Curi Pedrosa; Henryk Taper; Olivier Feron; Pedro Buc Calderon
Journal:  Biochem Pharmacol       Date:  2008-10-28       Impact factor: 5.858

8.  Lipophilicity of potent porphyrin-based antioxidants: comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins.

Authors:  Ivan Kos; Júlio S Rebouças; Gilson DeFreitas-Silva; Daniela Salvemini; Zeljko Vujaskovic; Mark W Dewhirst; Ivan Spasojević; Ines Batinić-Haberle
Journal:  Free Radic Biol Med       Date:  2009-04-08       Impact factor: 7.376

9.  Cell growth and size homeostasis in proliferating animal cells.

Authors:  Amit Tzur; Ran Kafri; Valerie S LeBleu; Galit Lahav; Marc W Kirschner
Journal:  Science       Date:  2009-07-10       Impact factor: 47.728

10.  Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade.

Authors:  Azmi Yerlikaya; Nuray Erin
Journal:  Int J Mol Med       Date:  2008-12       Impact factor: 4.101

View more
  28 in total

Review 1.  Ascorbic acid: chemistry, biology and the treatment of cancer.

Authors:  Juan Du; Joseph J Cullen; Garry R Buettner
Journal:  Biochim Biophys Acta       Date:  2012-06-20

2.  Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer.

Authors:  John A Cieslak; Robert K Strother; Malvika Rawal; Juan Du; Claire M Doskey; Samuel R Schroeder; Anna Button; Brett A Wagner; Garry R Buettner; Joseph J Cullen
Journal:  Free Radic Biol Med       Date:  2015-02-26       Impact factor: 7.376

3.  Mn porphyrin-based SOD mimic, MnTnHex-2-PyP(5+), and non-SOD mimic, MnTBAP(3-), suppressed rat spinal cord ischemia/reperfusion injury via NF-κB pathways.

Authors:  T Celic; J Španjol; M Bobinac; A Tovmasyan; I Vukelic; J S Reboucas; I Batinic-Haberle; D Bobinac
Journal:  Free Radic Res       Date:  2014-10-10

4.  Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death.

Authors:  Myron K Evans; Artak Tovmasyan; Ines Batinic-Haberle; Gayathri R Devi
Journal:  Free Radic Biol Med       Date:  2013-12-12       Impact factor: 7.376

Review 5.  Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2018-08-28       Impact factor: 8.401

Review 6.  Manganese superoxide dismutase, MnSOD and its mimics.

Authors:  Sumitra Miriyala; Ivan Spasojevic; Artak Tovmasyan; Daniela Salvemini; Zeljko Vujaskovic; Daret St Clair; Ines Batinic-Haberle
Journal:  Biochim Biophys Acta       Date:  2011-12-09

7.  A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeutics.

Authors:  Artak Tovmasyan; Clarissa G C Maia; Tin Weitner; Sebastián Carballal; Romulo S Sampaio; Dominik Lieb; Robert Ghazaryan; Ivana Ivanovic-Burmazovic; Gerardo Ferrer-Sueta; Rafael Radi; Julio S Reboucas; Ivan Spasojevic; Ludmil Benov; Ines Batinic-Haberle
Journal:  Free Radic Biol Med       Date:  2015-05-28       Impact factor: 7.376

8.  Radiation-Mediated Tumor Growth Inhibition Is Significantly Enhanced with Redox-Active Compounds That Cycle with Ascorbate.

Authors:  Artak Tovmasyan; Jacqueline C Bueno-Janice; Melba C Jaramillo; Romulo S Sampaio; Julio S Reboucas; Natalia Kyui; Ludmil Benov; Brian Deng; Ting-Ting Huang; Margaret E Tome; Ivan Spasojevic; Ines Batinic-Haberle
Journal:  Antioxid Redox Signal       Date:  2018-03-27       Impact factor: 8.401

Review 9.  Simple biological systems for assessing the activity of superoxide dismutase mimics.

Authors:  Artak Tovmasyan; Julio S Reboucas; Ludmil Benov
Journal:  Antioxid Redox Signal       Date:  2013-10-19       Impact factor: 8.401

Review 10.  SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Emily R H Roberts; Zeljko Vujaskovic; Kam W Leong; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2013-10-01       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.